Drugs & Therapy Perspectives | 1996(08) articles
- An expanding range of atypical antipsychotic agents to choose from
- When and how should insulin be used in elderly patients with NIDDM?
- Treatment implications of antibacterial resistance in long-term care facilities
- Cautious approach warranted for ERT in breast cancer survivors
- Cost considerations in using filgrastim to prevent antineoplastic therapy-induced neutropenia